Betamethasone Sodium Phosphate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 4 mg/ml or 6 mg/2 mL ampoule
Reference Brands: Celestone®, Soluspan, Betnesol®, Diprospan®(EU & US)
Category:
Allergy Medication
Fast-acting corticosteroid injection used for allergic reactions, asthma, and inflammation. Available in 4 mg/mL or 6 mg/2 mL for IM/IV use. Marketed as Celestone®, Betnesol®, and generics in the EU & US.
Betamethasone Sodium Phosphate is available in Injection
and strengths such as 4 mg/ml or 6 mg/2 mL ampoule.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Betamethasone Sodium Phosphate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Betamethasone Sodium Phosphate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Betamethasone Sodium Phosphate Injection is a rapid-acting corticosteroid used for managing severe allergic reactions, autoimmune conditions, asthma, and rheumatic disorders. It is typically available as 4 mg/mL or 6 mg/2 mL in IM or IV formulations, often under brands like Celestone® Soluspan, Betnesol®, and various generics. Approved and marketed across the EU and US, it is manufactured in GMP-compliant facilities for hospital supply, emergency care, and bulk distribution.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing